Thiol/Disulfide homeostasis in patients with rheumatoid arthritis

1. JALIL SF., ARSHAD M., BHATTI A., AHMAD J., AKBAR F., ALI S., et al. Review -Rheumatoid arthritis: What have we learned about the causing factors? Pak J Pharm Sci. 2016;29(2):629-45.Search in Google Scholar

2. LOZA E., LAJAS C., ANDREU JL., BALSA A., GONZALEZ-ALVARO I., ILLERA O., et al. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int. 2015;35(3):445-58.10.1007/s00296-014-3196-725543267Search in Google Scholar

3. TURESSON C., MATHSSON L., JACOBSSON LT., STURFELT G., RÖNNELID J. Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2013;72(12):2047-8.10.1136/annrheumdis-2013-20351023740235Search in Google Scholar

4. KAPITANY A., ZILAHI E., SZANTO S., SZÜCS G., SZABO Z., VEGVARI A., et al. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Ann N Y Acad Sci. 2005;1051:263-70.10.1196/annals.1361.06716126967Search in Google Scholar

5. FOX DA., GIZINSKI A., MORGAN R., LUNDY SK. Cell-cell interactions in rheumatoid arthritis synovium. Rheum Dis Clin North Am. 2010;36(2):311-23.10.1016/j.rdc.2010.02.004287939720510236Search in Google Scholar

6. CHIMENTI MS., TRIGGIANESE P., CONIGLIARO P., CANDI E., MELINO G., PERRICONE R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015;6:e1887.10.1038/cddis.2015.246465044226379192Search in Google Scholar

7. MERRY P., WINYARD PG., MORRIS CJ., GROOTVELD M., BLAKE DR. Oxygen free radicals, inflammation, and synovitis: the current status. Ann Rheum Dis. 1989;48(10):864-70.10.1136/ard.48.10.86410038972684056Search in Google Scholar

8. HITCHON CA., EL-GABALAWY HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004;6(6):265-78.10.1186/ar1447106487415535839Search in Google Scholar

9. IÇME F., EREL Ö., AVCI A., SATAR S., GÜLEN M., ACEHAN S. The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. Turk J Med Sci. 2015;45(4):947-53.10.3906/sag-1402-9626422872Search in Google Scholar

10. KUNDI H., ATES I., KIZILTUNC E., CETIN M., CICEKCIOGLU H., NESELIOGLU S., et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-71.10.1016/j.ajem.2015.06.01626143314Search in Google Scholar

11. KUNDI H., EREL Ö., BALUN A., ÇIÇEKÇIOĞLU H., CETIN M., KIZILTUNÇ E., et al. Association of thiol/disulfide ratio with syntax score in patients with NSTEMI. Scand Cardiovasc J. 2015;49(2):95-100.10.3109/14017431.2015.101315325658436Search in Google Scholar

12. EREL O., NESELIOGLU S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-32.10.1016/j.clinbiochem.2014.09.02625304913Search in Google Scholar

13. VILLENEUVE E., NAM J., EMERY P. 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Rev Bras Reumatol. 2010;50(5):481-3.10.1590/S0482-50042010000500001Search in Google Scholar

14. TEKEOĞLU I., HARMAN H., SAĞ S., ALTINDIŞ M., KAMANLI A., NAS K. Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis. Cytokine. 2016;83:171-5.10.1016/j.cyto.2016.04.00927152709Search in Google Scholar

15. CURE E., CUMHUR CURE M., TUMKAYA L., KALKAN Y., AYDIN I., KIRBAS A., et al. Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats. Biomed Res Int. 2014;2014:907915.10.1155/2014/907915391432624551855Search in Google Scholar

16. JIA Z., HE J. Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2. Exp Ther Med. 2016;11(2):655-9.10.3892/etm.2015.2908473402126893662Search in Google Scholar

17. CACCIAPAGLIA F., ANELLI MG., RIZZO D., MORELLI E., SCIOSCIA C., MAZZOTTA D., et al. Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo. 2015;67(3):97-102.10.4081/reumatismo.2015.82926876188Search in Google Scholar

18. MATEEN S., MOIN S., KHAN AQ., ZAFAR A., FATIMA N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. Plos One. 2016;11(4):e0152925.10.1371/journal.pone.0152925482027427043143Search in Google Scholar

19. FILIPPIN LI., VERCELINO R., MARRONI NP., XAVIER RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. 2008;152(3):415-22.10.1111/j.1365-2249.2008.03634.x245319618422737Search in Google Scholar

20. KALPAKCIOGLU B., SENEL K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. 2008;27(2):141-5.10.1007/s10067-007-0746-317912575Search in Google Scholar

21. ALTINDAG O., KARAKOC M., KOCYIGIT A., CELIK H., SORAN N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem. 2007;40(3-4):167-71.10.1016/j.clinbiochem.2006.10.00617196579Search in Google Scholar

22. EL-BANNA H., JIMAN-FATANI A. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:379.10.1186/1471-2474-15-379Search in Google Scholar

23. NAKAJIMA A., AOKI Y., SHIBATA Y., SONOBE M., TERAJIMA F., TAKAHASHI H., et al. Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis. Mod Rheumatol. 2014;24(6):926-30.10.3109/14397595.2014.891495Search in Google Scholar

24. HIRAO M., YAMASAKI N., OZE H., EBINA K., NAMPEI A., KAWATO Y., et al. Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol Int. 2012;32(12):4041-5.10.1007/s00296-011-2135-0Search in Google Scholar

25. MORALES K., OLESEN MN., POULSEN ET., LARSEN UG., ENGHILD JJ., PETERSEN SV. The effects of hypochlorous acid and neutrophil proteases on the structure and function of extracellular superoxide dismutase. Free Radic Biol Med. 2015;81:38-46.10.1016/j.freeradbiomed.2014.12.027Search in Google Scholar

26. AOYAMA K., NAKAKI T. Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1). Molecules. 2015;20(5):8742-58.10.3390/molecules20058742Search in Google Scholar

27. NAGY P. Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxid Redox Signal. 2013;18(13):1623-41.10.1089/ars.2012.4973Search in Google Scholar

28. TURELL L., CARBALLAL S., BOTTI H., RADI R., ALVAREZ B. Oxidation of the albümin thiol to sulfenic acid and its implications in the intravascular compartment. Braz J Med Biol Res. 2009;42(4):305-11.10.1590/S0100-879X2009000400001Search in Google Scholar

29. ELLMAN G., LYSKO H. A precise method for the determination of whole blood and plasma sulfhydryl groups. Anal Biochem. 1979;93(1):98-102.10.1016/S0003-2697(79)80122-0Search in Google Scholar

30. YUCEL A., SANHAL CY., DAGLAR K., KARA O., UYGUR D., EREL O. Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever. Redox Rep. 2016;21(6):287-91.10.1080/13510002.2016.1168590683768027077456Search in Google Scholar

31. ATES I., OZKAYAR N., INAN B., YILMAZ FM., TOPCUOGLU C., NESELIOGLU S., et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. J Am Soc Hypertens. 2016;10(2):159-66.10.1016/j.jash.2015.12.00826725016Search in Google Scholar

32. ATES I., KAPLAN M., YUKSEL M., MESE D., ALISIK M., EREL Ö., et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51(1):47-51.10.1007/s12020-015-0784-626547218Search in Google Scholar

33. CHEN Z., MA T., HUANG C., ZHANG L., HU T., LI J. MIF, a potential therapeutic target for rheumatoid arthritis? Rheumatol Int. 2014;34(10):1481-2.10.1007/s00296-013-2877-y24463567Search in Google Scholar

34. GIUSTARINI D., LORENZINI S., ROSSI R., CHINDAMO D., DI SIMPLICIO P., MARCOLONGO R. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(2):205-12.Search in Google Scholar

35. POPA C., VAN TITS LJ., BARRERA P., LEMMERS HL., VAN DEN HOOGEN FH., VAN RIEL PL., et al. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis. 2009;68(6):868-72.10.1136/ard.2008.09217118635596Search in Google Scholar

36. HEIDARI R., TAHERI V., RAHIMI HR., SHIRAZI YEGANEH B., NIKNAHAD H., NAJIBI A. Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants. Ren Fail. 2016;38(1):137-41.10.3109/0886022X.2015.109673126479898Search in Google Scholar